On April 13, 2026, the Delaware Court of Chancery dismissed all 12 claims asserted in The Gregory M. Raiff 2000 Trust v. Jenzabar, Inc., 2026 WL 992587 (Del. Ch. Apr. 13, 2026). Some claims were exclusively derivative, some were unripe, some were time-barred, and some were deficient for a combination of these reasons. The court
Latest Post
More Posts
Securities Litigation Against Life Sciences Companies: 2025
With a Fresh Look at the Facts in Columbia Pipeline, the Delaware Supreme Court Continues to Narrow Aiding and Abetting Liability for Acquirers
Securities Litigation Against Life Sciences Companies: 2024
Court of Chancery Resolves Statutory Ambiguity in Favor of Boards Seeking to Increase a Corporation’s Number of Authorized Shares
Words Matter: Different Definitions of “Commercially Reasonable Efforts” Lead to Different Results in Drug-Development Earnout Disputes
In Case of First Impression, Court of Chancery Awards Expenditures Incurred in Third-Party Litigation as Breach of Contract Damages
Director Wins In Claim of Improper Removal – But Still Loses
Controller’s Ability to Appoint and Remove Directors at Will Insufficient to Establish Demand Futility
Securities Litigation Against Life Sciences Companies: 2023
Subscribe: Subscribe via RSS
Blogs
Firm/Org